Yoshihisa Mimura

2PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 02, 2026
Eosinophil Proportion May Serve as a Candidate Biomarker for Adverse Events in Patients With Urothelial Carcinoma Treated With Enfortumab Vedotin.

|Jul 01, 2026
Elevation of Eosinophil Proportion After Pembrolizumab Increases the Risk of Immune-Related Adverse Events in Patients With Bladder Cancer.

Pageof 1

Frequent Collaborators

2 joint publications

Taku Naiki

2 joint publications

Toshiharu Morikawa

2 joint publications

Yosuke Sugiyama

2 joint publications

Noriyasu Kawai